MariMed Inc (MRMD)
OTHER OTC:MRMD
Want to see MRMD full AI Analyst Report?
Total Valuation
MariMed has a market cap or net worth of $29.94M. The enterprise value is $120.15M.
Market Cap$29.94M
Enterprise Value$120.15M
Share Statistics
MariMed has 399,266,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding399,266,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MariMed’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -1.38%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-1.38%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee223.53K
Profits Per Employee-20.26K
Employee Count715
Asset Turnover0.79
Inventory Turnover2.79
Valuation Ratios
The current PE Ratio of MariMed is ―. MariMed’s PEG ratio is -0.15.
PE Ratio―
PS Ratio0.21
PB Ratio0.66
Price to Fair Value0.66
Price to FCF5.25
Price to Operating Cash Flow4.06
PEG Ratio-0.15
Income Statement
In the last 12 months, MariMed had revenue of 159.83M and earned -14.48M in profits. Earnings per share was -0.04.
Revenue159.83M
Gross Profit57.88M
Operating Income-2.07M
Pretax Income-10.86M
Net Income-14.48M
EBITDA9.44M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was 7.35M and capital expenditures -1.52M, giving a free cash flow of 5.83M billion.
Operating Cash Flow7.35M
Free Cash Flow5.83M
Free Cash Flow per Share0.01
Dividends & Yields
MariMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-6.25%
50-Day Moving Average0.08
200-Day Moving Average0.10
Relative Strength Index (RSI)51.82
Average Volume (3m)1.40M
Important Dates
MariMed upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
MariMed as a current ratio of 1.00, with Debt / Equity ratio of 202.76%
Current Ratio1.00
Quick Ratio0.38
Debt to Market Cap2.55
Net Debt to EBITDA9.66
Interest Coverage Ratio-0.28
Taxes
In the past 12 months, MariMed has paid 3.59M in taxes.
Income Tax3.59M
Effective Tax Rate-0.33
Enterprise Valuation
MariMed EV to EBITDA ratio is 13.29, with an EV/FCF ratio of 19.22.
EV to Sales0.79
EV to EBITDA13.29
EV to Free Cash Flow19.22
EV to Operating Cash Flow16.31
Balance Sheet
MariMed has $7.94M in cash and marketable securities with $98.14M in debt, giving a net cash position of -$90.21M billion.
Cash & Marketable Securities$7.94M
Total Debt$98.14M
Net Cash-$90.21M
Net Cash Per Share-$0.23
Tangible Book Value Per Share$0.02
Margins
Gross margin is 36.02%, with operating margin of -1.29%, and net profit margin of -9.06%.
Gross Margin36.02%
Operating Margin-1.29%
Pretax Margin-6.80%
Net Profit Margin-9.06%
EBITDA Margin5.91%
EBIT Margin-1.29%
Analyst Forecast
The average price target for MariMed is $0.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$0.25
Price Target Upside257.14% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast2.23%
EPS Growth Forecast25.23%